Purpose: Charcot-Marie-Tooth Disease type 1A (CMT1A) is caused by a duplication of the peripheral myelin protein gene 22 at chromosome 17p11.2-12. There is limited data regarding whether body mass index (BMI) affects electrophysiological or clinical data in those with CMT1A.
C harcot-Marie-Tooth disease type 1A (CMT1A) is the most common subtype of Charcot-Marie-Tooth (CMT) disease and represents 80% of all demyelinating CMT. 1 CMT1A is caused by a duplication of the peripheral myelin protein gene 22 (PMP 22) at chromosome 17p11.2-12, which leads to increased PMP 22 expression, and resulting in defective myelin stability and abnormal Schwann cell growth and differentiation. 2 Despite the known pathophysiology of CMT1A, previous reports have shown that diabetes mellitus type II can lower ulnar compound motor action potential amplitude at a significant level in those with CMT1A, can worsen the CMT examination score (CMTES) as well as can result in more severe motor and sensory impairments in those with CMT1A while controlling for age. 1, 3 Various hypothesis of how diabetes mellitus type II worsens electrophysiological and clinical outcomes for those with CMT1A include a possible impairment of axonal transport and function of mitochondria in patients with diabetes. 3 Typically, patients with diabetes mellitus type II have an elevated body mass index (BMI). 4 A high BMI can result in a prolonged distal motor latency in the median nerve, and a prolonged F-wave minimal latency in the tibial nerve in adults without any medical comorbidity. 5 One study has shown that a higher BMI is correlated with lower sensory and mixed nerve amplitude potentials. 6 Another study suggested that BMI has no effect on nerve conduction velocities. 7 Data on how BMI affects nerve conduction studies (NCS) in CMT1A, however, is limited. A previous study analyzed only 11 patients with elevated BMI and CMT1A, and found no significant difference in ulnar NCS, ulnar compound motor action potential, and CMTNS compared with controls. 1 The following study aims to discover whether one's BMI can affect NCS or the CMTES in those with CMT1A.
MATERIALS AND METHODS

Patients and Chart Review
This study was approved by the Institutional Review Board of the University of Iowa, and subjects signed an informed consent. A database of all patients with CMT is maintained at the University of Iowa. There are more than 1,100 patients with CMT and more than 300 patients with CMT1A. CMT1A is diagnosed with clinical genetic testing for the presence of a 1.4 Mb duplication on chromosome 17p11.2. If a patient has a first or second degree relative with a known duplication, then a diagnosis is established with uniform motor conduction slowing of the median or ulnar nerve between 10 and 35 m per second.
We analyzed the database for patients who had CMT1A and had a known BMI as well as a documented ulnar nerve conduction testing performed at the University of Iowa Hospitals and Clinics. We performed a retrospective analysis of data from electrodiagnostic testing (NCS), BMI (body mass index), sex, and age at the time of the electrodiagnostic testing. Data from 101 patients with CMT1A and a known BMI as well as electrodiagnostic testing at the University of Iowa were obtained. Those with a known history of diabetes (8 patients) or chemotherapy (1 patient) were excluded.
Calculation of Neuropathy Score
A CMTES was calculated using a modified scale that had been validated previously as a measure of disability caused by CMT. 8 Using this scale, the level of impairment is classified as follows: score of 0 to 10, mild impairment; score of 11 to 20, moderate impairment; and score $ 21, significant impairment. 8 The CMTES has seven scored components: three are symptoms and four are signs observed by a clinician. Each measurement is scored from 0 to 4, for a possible total of 28 points (see Appendix 1, Supplemental Digital Content 1, http://links.lww. com/JCNP/A24). In addition, a CMTNSv2 and its components were calculated using a Rasch model. 9 The CMTNSv2 is the CMTES plus two additional components from electrodiagnostic testing resulting in a total of 36 points (see Appendix 1, Supplemental Digital Content 1, http://links.lww.com/JCNP/A24).
Electrodiagnostic Testing
Ulnar motor nerve conduction studies and radial sensory nerve conduction studies of the left upper extremity were performed by standard techniques using conventional methods (Nihon Kohden system). Amplitudes measured from baseline to peak were used. Skin temperature was maintained above 328C and surface electrodes were used. Ulnar compound motor action potential was recorded from the abductor digiti minimi while stimulating at the wrist, below, and above elbow. Ulnar and radial responses are routinely used because peroneal and sural potentials are typically absent even in demyelinating CMT. 8 The following variables were obtained from the electrodiagnostic testing: compound motor action potential, sensory nerve action potential, motor conduction velocity, sensory conduction velocity distal motor latency, and distal sensory latencyF-waves were not evaluated routinely in the CMT clinic.
Statistical Analysis
Percentages and mean were compared using the Student ttest, and differences were considered significant at P , 0.03 accounting for multiple comparisons. Nerve conduction parameters were compared among two groupsdthose with a high BMI greater than or equal to 30 (clinical definition of obesity) and those with a low or normal BMI less than 30. A regression model was made to compare results confounded by BMI and age.
RESULTS
Results from 101 patients were sorted by BMI and age. The overall average age was 41 and average BMI was 28; there were 50 females and 51 males. There were 32 patients with obesity (mean BMI 36) and 69 patients without obesity (mean BMI 23). Those with a higher BMI were 8 years older than those with a lower BMI (age 45 compared with 37). The youngest patient was 3 years old as in CMT1A, neurophysiologic abnormalities are present in all children from the age of 2 years. 10 Ulnar motor nerve conduction responses were obtained in all patients. Eighty-nine of 101 (88%) patients had absent radial sensory responses. Table 1 demonstrates how ulnar nerve conduction parameters are not significantly different and how the CMTES is significantly different from those with obesity compared with those without obesity. It also demonstrates that age is significantly different, and thus age seems to be a confounding variable. Tables 2 and 3 demonstrate how there is a significant difference between older age versus younger age in two of the three nerve conduction parameters. Table 4 illustrates ulnar motor nerve conduction velocity changes when controlling for either age or BMI. Table 4 shows that the CMTNS is the only measure significantly associated with BMI after controlling for the effects of age, and that ulnar nerve conduction study parameters are not affected by BMI. Age is positively associated with two measures (ulnar motor nerve conduction velocity and CMTES) after adjusting for BMI as seen in Table 4 below. Table 5 shows how age and BMI affect the CMTNSv2. Each component of the CMTNSv2 worsened over time with age when controlling for the effects of BMI. A higher BMI lead to worsening pinprick loss and motor strength in the lower extremities.
DISCUSSION
Previous reports have suggested that in adults with no medical comorbidities, a higher BMI results in prolonged distal motor latencies of the median nerve, and lower sensory and mixed nerve amplitude potentials. 5, 6 Little has been investigated on the effect of BMI on NCS in those with CMT1A.
Results from our analysis of BMI, ulnar motor nerve conduction studies, radial sensory nerve conduction studies, age, and CMTES in 101 patients with CMT1A show that BMI alone when controlled for age does not affect ulnar motor nerve conduction studies as reported previously. 1 A radial sensory nerve action potential was obtained more often in those who were nonobese compared with those who were. It is uncertain if this result was secondary to the obesity itself or if excessive fat deposition at stimulation or recording sites might interfere could have interfered with obtaining the NCS results.
These results confirm our hypothesis that the neurophysiological patterns of CMT1A are caused by varying degrees of increased PMP 22 expression resulting in defective myelin stability and genetic modifiers rather than by the epigenetic effects of BMI.
On investigating further, we noticed that BMI was associated positively with a Rasch version of the CMTNSv2da higher BMI resulted in a worse (or higher) CMTNSv2. This was analyzed further by investigating each component of the CMTNSv2 and performing a regression of these components with BMI while controlling for age. The results showed that a higher BMI worsened lower extremity pinprick loss and lower extremity motor strength on examination.
Although it is possible that a higher BMI can result in worsening lower extremity strength and pinprick sensation, it is also possible that worsening lower extremity strength and pinprick sensation can lead to a higher BMI due to the lack of ability to do physical activity as a result of these symptoms.
Increasing age has been known to affect CMT1A over time and our results confirm this. Older age is associated with a higher (or worse) CMTES; Shy et al. reported an average increase of 0.69 points of the CMTES score per year for natural progression. 11 Specifically, in our study, an increasing age affected or worsened all parameters of the CMTES. Age resulted in the ulnar motor nerve velocity to be faster, which is unexpected as previous reports involving subjects without CMT1A suggest age to slow nerve conduction velocity due to a suspected decrease in number of nerve fibers with increasing age. 12, 13 This result is possibly due to a technical artifact as wrist-to-elbow measures can be falsely increased due to distance measurement factors including extra skin tissue, which can be seen with aging.
A limitation of our study includes the fact that only an ulnar motor response and radial sensory response was evaluated for each patient. In addition, the unusual result of the ulnar motor nerve conduction velocity increasing with age signals that there could possibly be technical factors that could have affected our data. 
